Metagenomi Therapeutics (MGX) Assets (2023 - 2026)
Metagenomi Therapeutics (MGX) posted quarterly Assets of $197.0 million for Q1 2026, down 33.88% year-over-year from $297.9 million in Q1 2025, and down 10.92% quarter-over-quarter from $221.1 million in Q4 2025.
Metagenomi Therapeutics (MGX) Assets (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has reported Assets for 4 consecutive years, with $197.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 33.88% year-over-year to $197.0 million; the TTM figure through Mar 2026 stood at $197.0 million (down 33.88% YoY), while the FY2025 annual figure was $221.1 million, down 31.88% from the prior year.
- Assets retreated to $197.0 million in Q1 2026 per MGX's latest filing, from $221.1 million in the prior quarter.
- Across five years, Assets topped out at $415.4 million in Q1 2024 and bottomed at $197.0 million in Q1 2026.
- Historically, Assets has averaged $308.5 million across 4 years, with a median of $311.2 million in 2024.
- Annual changes were most pronounced in 2024 — Assets declined 11.03% — and 2026, when it slumped 33.88%.
- Metagenomi Therapeutics' Assets stood at $364.8 million in 2023, then declined by 11.03% to $324.6 million in 2024, then slumped by 31.88% to $221.1 million in 2025, then retreated by 10.92% to $197.0 million in 2026.
- Business Quant data shows MGX's Assets at $197.0 million in Q1 2026, $221.1 million in Q4 2025, and $247.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 19.82 Bn |
| 10 | Metagenomi Therapeutics | 46.32 Mn | 46.32 Mn | - | 173.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 173.70 Mn |
| Mar 31, 2026 | 196.95 Mn |
| Dec 31, 2025 | 221.10 Mn |
| Sep 30, 2025 | 247.94 Mn |
| Jun 30, 2025 | 272.28 Mn |
| Mar 31, 2025 | 297.87 Mn |
| Dec 31, 2024 | 324.60 Mn |
| Sep 30, 2024 | 358.35 Mn |
| Jun 30, 2024 | 385.91 Mn |
| Mar 31, 2024 | 415.40 Mn |
| Dec 31, 2023 | 364.84 Mn |